Non-Hodgkin's lymphoma of the nasopharynx, paranasal sinus and palate.
Twenty-two patients with non-Hodgkin's lymphoma of the nasopharynx, paranasal sinuses or palate were treated between 1952 and 1980. The histology was reviewed by one histopathologist and 77% of cases were classified as grade 2 non-Hodgkin's lymphoma. Forty-five per cent of patients relapsed after initial treatment and 41% of all patients died from lymphoma. The 5-year survival ranged from 22% for the nasopharynx to 80% for the palate.
Makepeace
A R
AR
Meyerstein Institute of Radiotherapy and Oncology, Middlesex Hospital, London, UK.
Fermont
D C
DC
Bennett
M H
MH
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D010157:Palatal Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D010255:Paranasal Sinus Neoplasms / Q000401:mortality / Q000532:radiotherapy*